EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Putting the STING back into BH3-mimetic drugs for TP53-mutant blood cancers

Sarah T Diepstraten, Yin Yuan, John E La Marca, Savannah Young, Catherine Chang, Lauren Whelan, Aisling M Ross, Karla C Fischer, Giovanna Pomilio, Rhiannon Morris, Angela Georgiou, Veronique Litalien und 5 weitere

Cancer Cell · 2024-05 · 42 (5) · 850-868.e9

DOI: 10.1016/j.ccell.2024.04.004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Cell, 2024-05. Verfasst von Sarah T Diepstraten und 16 weiteren Autor:innen. Beteiligte Einrichtung: Blood Cells and Blood Cancer Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australia; Department of Medical…. Hauptthemen laut MEDLINE: Tumor Suppressor Protein p53, Membrane Proteins, Apoptosis. Die Arbeit wurde bisher 57-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Royal College of Pathologists of Australasia, National Health and Medical Research Council, Cass Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor Suppressor Protein p53Membrane ProteinsApoptosisHumansAnimalsMiceCell Line, TumorMutationHematologic NeoplasmsProto-Oncogene Proteins c-bcl-2Peptide FragmentsAntineoplastic AgentsSignal TransductionProto-Oncogene Proteins

Stichwörter der Autor:innen

BH3-mimetic drugsSTINGacute myeloid leukemiaapoptosisblood cancerlymphomap53

Substanzen

Tumor Suppressor Protein p53Membrane ProteinsProto-Oncogene Proteins c-bcl-2Peptide FragmentsAntineoplastic AgentsProto-Oncogene Proteins

Autor:innen und Institutionen

  • Blood Cells and Blood Cancer Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australia; Department of Medical Biology, University of Melbourne, Parkville, VIC 3052, Australia. Ele…
  • Blood Cells and Blood Cancer Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australia; Department of Medical Biology, University of Melbourne, Parkville, VIC 3052, Australia; Dep…
  • Blood Cells and Blood Cancer Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australia; Department of Medical Biology, University of Melbourne, Parkville, VIC 3052, Australia; Gen…
  • Blood Cells and Blood Cancer Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australia.
  • Blood Cells and Blood Cancer Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australia; School of Medicine, Bernal Institute, Limerick Digital Cancer Research Centre & Health Rese…
  • Blood Cells and Blood Cancer Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australia; Department of Medical Biology, University of Melbourne, Parkville, VIC 3052, Australia.

Förderung

  • Royal College of Pathologists of Australasia
  • National Health and Medical Research Council
  • Cass Foundation
  • RCPA Foundation
  • State Government of Victoria
  • Victorian Cancer Agency
  • Servier
  • Australian Government Department of Health and Aged Care

Zitieren

APA

Diepstraten, S. T., Yuan, Y., La Marca, J. E., Young, S., Chang, C., Whelan, L., Ross, A. M., Fischer, K. C., Pomilio, G., Morris, R., Georgiou, A., Litalien, V., Brown, F. C., Roberts, A. W., Strasser, A., Wei, A. H., & Kelly, G. L. (2024). Putting the STING back into BH3-mimetic drugs for TP53-mutant blood cancers. Cancer Cell, 42(5), 850-868.e9. https://doi.org/10.1016/j.ccell.2024.04.004

Vancouver

Diepstraten ST, Yuan Y, La Marca JE, Young S, Chang C, Whelan L, et al. Putting the STING back into BH3-mimetic drugs for TP53-mutant blood cancers. Cancer Cell. 2024;42(5):850-868.e9. doi:10.1016/j.ccell.2024.04.004

BibTeX
@article{Diepstraten2024,
  author = {Diepstraten, Sarah T and Yuan, Yin and La Marca, John E and Young, Savannah and Chang, Catherine and Whelan, Lauren and Ross, Aisling M and Fischer, Karla C and Pomilio, Giovanna and Morris, Rhiannon and Georgiou, Angela and Litalien, Veronique and Brown, Fiona C and Roberts, Andrew W and Strasser, Andreas and Wei, Andrew H and Kelly, Gemma L},
  title = {Putting the STING back into BH3-mimetic drugs for TP53-mutant blood cancers},
  journal = {Cancer Cell},
  year = {2024},
  volume = {42},
  number = {5},
  pages = {850--868.e9},
  doi = {10.1016/j.ccell.2024.04.004}
}
Kostenlos starten →